MedPath

Clinical study of Kaifei mixture in the treatment of children with community-acquired pneumonia

Early Phase 1
Recruiting
Conditions
Community-Acquired Pneumonia in Children
Registration Number
ITMCTR2024000112
Lead Sponsor
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) Child patients aged 2-14 years old
2) Child patients with a primary diagnosis of CAP
3) Child patients diagnosed with dyspnea with phlegm due to lung wind including syndrome of toxic heat obstructing the lung or phlegm-heat obstructing the lung
4) Within 10 days of course of disease
5) Signed an informed consent form voluntarily

Exclusion Criteria

1) Critically illness and unable to take Chinese medicine
2) Child patients with severe liver and kidney function impairment
3) Child patients with allergic reaction to Chinese medicine ingredients
4) Child patients with congenital airway malformation or primary immunodeficiency disease

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath